BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22441310)

  • 1. Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy.
    Salonia A; Abdollah F; Capitanio U; Gallina A; Suardi N; Briganti A; Zanni G; Ferrari M; Castiglione F; Clementi MC; Rigatti P; Montorsi F
    World J Urol; 2013 Apr; 31(2):275-80. PubMed ID: 22441310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy.
    Salonia A; Gallina A; Abdollah F; Briganti A; Capitanio U; Suardi N; Ferrari M; Raber M; Colombo R; Freschi M; Rigatti P; Montorsi F
    World J Urol; 2012 Aug; 30(4):533-9. PubMed ID: 21935733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer.
    Schnoeller T; Jentzmik F; Rinnab L; Cronauer MV; Damjanoski I; Zengerling F; Ghazal AA; Schrader M; Schrader AJ
    World J Urol; 2013 Apr; 31(2):253-9. PubMed ID: 22763628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Serum Sex Hormone-Binding Globulin Level Is an Independent Predictor of Biochemical Outcome After Radical Prostatectomy.
    Lee JK; Byun SS; Lee SE; Hong SK
    Medicine (Baltimore); 2015 Jul; 94(28):e1185. PubMed ID: 26181566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
    Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy.
    Salonia A; Abdollah F; Capitanio U; Suardi N; Briganti A; Gallina A; Colombo R; Ferrari M; Castagna G; Rigatti P; Montorsi F
    Clin Cancer Res; 2012 Jul; 18(13):3648-57. PubMed ID: 22589393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy.
    Salonia A; Gallina A; Briganti A; Suardi N; Capitanio U; Abdollah F; Bertini R; Freschi M; Rigatti P; Montorsi F
    Cancer; 2011 Nov; 117(22):5029-38. PubMed ID: 21495024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
    Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome.
    Vesely S; Jarolim L; Schmidt M; Minarik I; Dusek P; Babjuk M
    World J Urol; 2013 Apr; 31(2):299-304. PubMed ID: 22684375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence.
    Skove SL; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moreira DM; Freedland SJ
    Urology; 2017 Oct; 108():129-134. PubMed ID: 28735016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.
    Freedland SJ; Terris MK; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Aronson WJ;
    J Urol; 2004 Jun; 171(6 Pt 1):2215-20. PubMed ID: 15126788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer.
    Boehm K; Beyer B; Tennstedt P; Schiffmann J; Budaeus L; Haese A; Graefen M; Schlomm T; Heinzer H; Salomon G
    World J Urol; 2015 Jun; 33(6):801-6. PubMed ID: 24989847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating sex steroids and prostate cancer: introducing the time-dependency theory.
    Salonia A; Abdollah F; Capitanio U; Suardi N; Gallina A; Castagna G; Clementi MC; Briganti A; Rigatti P; Montorsi F
    World J Urol; 2013 Apr; 31(2):267-73. PubMed ID: 23283410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
    Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
    Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies).
    Brureau L; Emeville E; Multigner L; Blanchet P
    Prog Urol; 2018 Jun; 28(8-9):442-449. PubMed ID: 29789237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Waldert M; Schatzl G; Swietek N; Rom M; Klatte T
    J Urol; 2012 Sep; 188(3):792-7. PubMed ID: 22818139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
    Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
    World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.